Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Efficacy of Oral Tofacitinib in Combination of Narrow Band UVB in Treatment of Vitiligo
Official title: Efficacy of Oral Tofacitinib in Combination With Narrow Band UVB in the Treatment of Vitiligo
Status: Closed to new participants
Description:
20 patients will be enrolled. All were given narrowband UVB . 10 wil be give oral azathriopfine . 10 will be given tofacitinib
Phase: Phase 1.
What is being studied: drugs — Azathioprine, Tofacitinib.
Who can take part: ages 18 Years to 60 Years, 20 participants planned.
Enrollment status: the registry has not updated this study since its planned completion date, so its current status is unclear. The study started 01 March 2025 and was due to finish 30 September 2025.
Source: ClinicalTrials.gov, NCT07044141 (https://clinicaltrials.gov/study/NCT07044141).
Start date: March 01, 2025
Completion date: September 30, 2025
Organizer: Lahore General Hospital
Link: https://clinicaltrials.gov/study/NCT07044141
The registry does not list a contact for this study. Use the link above to reach the study record on ClinicalTrials.gov.
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- I have a new job - should I tell colleagues about my vitiligo?
Starting a new job can be both exciting and nerve-wracking, — especially if you’re concerned about stares or questions regarding your skin. Taking a proactive approach can help ...
- Polypodium leucotomos as an adjunct treatment for vitiligo?
The tropical fern Polypodium leucotomos (also known as Polypodium aureum) and its relative Polypodium decumanumhave shown potential benefits for managing vitiligo and other auto...
- How smoking affects vitiligo?
Smoking is a common habit linked to numerous health risks, affecting multiple body systems and increasing various disease risks, including respiratory and cardiovascular issues....
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.